Advertisement

Topics

Insurers Battle Families Over Costly Drug for Fatal Disease

18:50 EDT 22 Jun 2017 | The New York Times News

The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.

Original Article: Insurers Battle Families Over Costly Drug for Fatal Disease

NEXT ARTICLE

More From BioPortfolio on "Insurers Battle Families Over Costly Drug for Fatal Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...